FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

19338005: 2 (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2023. Module: SNOMED CT core module

    Descriptions:

    Id Description Lang Type Status Case? Module
    32597014 Two en Synonym Active Entire term case insensitive SNOMED CT core module
    747350014 Two (qualifier value) en Fully specified name Inactive Only initial character case insensitive SNOMED CT core module
    3442102012 2 (qualifier value) en Fully specified name Active Entire term case insensitive SNOMED CT core module
    3442103019 2 en Synonym Active Entire term case insensitive SNOMED CT core module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    2 Is a General adjectival modifier false Inferred relationship Existential restriction modifier
    2 Is a Number false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Product containing precisely amiloride hydrochloride 10 milligram and furosemide 80 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ethinylestradiol 30 microgram and gestodene 75 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely lactic acid 50 milligram/1 gram and urea 100 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrocortisone 10 milligram/1 gram and oxytetracycline (as oxytetracycline hydrochloride) 30 milligram/1 gram conventional release cutaneous ointment Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely carbidopa 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrocortisone acetate 15 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release solution for ear or eye drops Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely amiloride hydrochloride 5 milligram and bumetanide 1 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely adapalene 1 milligram/1 gram and benzoyl peroxide 25 milligram/1 gram conventional release cutaneous gel Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 300 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely dantron 25 milligram and poloxamer 188 200 milligram/1 each conventional release oral capsule Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely lopinavir 100 milligram and ritonavir 25 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely dihydrocodeine tartrate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely erythromycin 40 milligram/1 milliliter and zinc acetate 12 milligram/1 milliliter conventional release cutaneous solution Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely chlorhexidine hydrochloride 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely metformin hydrochloride 1 gram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely captopril 50 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrocortisone 2 milligram/1 gram and lidocaine hydrochloride 10 milligram/1 gram conventional release cutaneous spray Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely bisoprolol 10 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely colloid sulfur 80 milligram/1 gram and resorcinol 20 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely felodipine 2.5 milligram and ramipril 2.5 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely estradiol 1 milligram and norethisterone acetate 500 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely chlortalidone 50 milligram and triamterene 50 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely benzoic acid 60 milligram/1 gram and salicylic acid 30 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely epinephrine 5 milligram/1 milliliter and guanethidine monosulfate 30 milligram/1 milliliter conventional release eye drops Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely amoxicillin 875 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely dantron 10 milligram/1 milliliter and docusate sodium 12 milligram/1 milliliter conventional release oral suspension Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 10 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely codeine phosphate 12.8 milligram and ibuprofen 200 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely lactic acid 40 milligram/1 gram and salicylic acid 120 milligram/1 gram conventional release cutaneous gel Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely acebutolol 200 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely chlorhexidine hydrochloride 10 milligram/1 gram and nystatin 100000 unit/1 gram conventional release cutaneous cream Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely estradiol valerate 2 milligram and medroxyprogesterone 20 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely dihydrocodeine tartrate 20 milligram and paracetamol 500 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ethinylestradiol 35 microgram and norethisterone 500 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely Podophyllum resin 200 milligram/1 gram and salicylic acid 250 milligram/1 gram conventional release cutaneous ointment Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 12.5 milligram and telmisartan 40 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely lidocaine 25 milligram/1 gram and prilocaine 25 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely sulfamethoxazole 400 milligram and trimethoprim 80 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely amiloride hydrochloride 5 milligram and hydrochlorothiazide 50 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely benzoyl peroxide 100 milligram/1 gram and potassium hydroxyquinoline sulfate 5 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ethinylestradiol 20 microgram and norethisterone acetate 1 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ezetimibe 10 milligram and simvastatin 40 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely metoclopramide hydrochloride 5 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely piperacillin (as piperacillin sodium) 4 gram and tazobactam (as tazobactam sodium) 500 milligram/1 vial powder for conventional release solution for injection Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely dried aluminium hydroxide gel 120 milligram/1 milliliter and magnesium hydroxide 60 milligram/1 milliliter conventional release oral suspension (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely heparinoid 2 milligram/1 gram and lauromacrogol 400 50 milligram/1 gram conventional release rectal ointment Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely amoxicillin (as amoxicillin sodium) 500 milligram and clavulanic acid (as clavulanate potassium) 100 milligram/1 vial powder for conventional release solution for injection Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely atenolol 100 milligram and chlortalidone 25 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely fusidic acid 20 milligram/1 gram and hydrocortisone acetate 10 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 12.5 milligram and quinapril 10 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ephedrine sulfate 15 milligram and theophylline 120 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem (as imipenem monohydrate) 500 milligram/1 vial powder for conventional release suspension for injection Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely lauromacrogol 30 milligram/1 gram and urea 50 milligram/1 gram conventional release cutaneous cream (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely lactic acid 50 milligram/1 gram and urea 100 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely dextran 70 1 milligram/1 milliliter and hypromellose 3 milligram/1 milliliter conventional release eye drops Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely adapalene 1 milligram/1 gram and benzoyl peroxide 25 milligram/1 gram conventional release cutaneous gel Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely mestranol 50 microgram and norethisterone 1 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely chlorhexidine hydrochloride 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrocortisone acetate 10 milligram/1 gram and sodium fusidate 20 milligram/1 gram conventional release cutaneous ointment Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely cetrimide 150 milligram/1 milliliter and chlorhexidine gluconate 15 milligram/1 milliliter conventional release cutaneous solution Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely dantron 25 milligram and poloxamer 188 200 milligram/1 each conventional release oral capsule Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely desogestrel 150 microgram and ethinylestradiol 20 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely atenolol 50 milligram and chlortalidone 12.5 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely pseudoephedrine hydrochloride 60 milligram and triprolidine hydrochloride 2.5 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely neomycin 3.5 milligram/1 milliliter and triamcinolone acetonide 1 milligram/1 milliliter conventional release ear drops Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely cetylpyridinium chloride 1 milligram/1 gram and lidocaine hydrochloride 3.3 milligram/1 gram conventional release dental gel Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely felodipine 5 milligram and ramipril 5 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely artemether 20 milligram and lumefantrine 120 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely lidocaine 70 milligram/1 gram and tetracaine 70 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrocortisone 10 milligram/1 gram and miconazole nitrate 20 milligram/1 gram conventional release cutaneous ointment Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely dantron 50 milligram and docusate sodium 60 milligram/1 each conventional release oral capsule Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely fluprednidene acetate 1 milligram/1 gram and miconazole nitrate 20 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release effervescent oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 10 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrocortisone 10 milligram/1 gram and oxytetracycline (as oxytetracycline hydrochloride) 30 milligram/1 gram conventional release cutaneous ointment Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely allantoin 20 milligram/1 gram and coal tar extract 50 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely caffeine 100 milligram and ergotamine tartrate 1 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier

    Start Previous Page 32 of 35 Next End

    This concept is not in any reference sets

    Back to Start